Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)
Nidhi Tandon; Surbhi Sidana; Angela Dispenzieri; Morie A. Gertz; Martha Q. Lacy; David Dingli; Francis K. Buadi; Amie L. Fonder; Suzanne R. Hayman; Yi Lisa Hwa; Miriam A. Hobbs; Prashant Kapoor; Wilson I. Gonsalves; Nelson Leung; Ronald S. Go; John A. Lust; Stephen J. Russell; Robert A. Kyle; S. Vincent Rajkumar; Shaji K. Kumar
Author Information: Division of Hematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.